Previous 10 | Next 10 |
2023-03-22 09:25:07 ET The U.K.-based nanocap biotech TC Biopharm ( NASDAQ: TCBP ) announced a major restructuring initiative on Wednesday indicating plans to reduce up to 30% of its staff count, mostly within the first half of 2023. The company expects to realize more tha...
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead PR Newswire Extends cash runway Realigned to reflect corporate strategic vision EDINBURGH, Scotland , March 22, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPh...
TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2) PR Newswire EDINBURGH, Scotland , March 16, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a cli...
2023-03-15 12:48:54 ET Gainers: Moolec ( MLEC ) +86% . Thermo Genesis ( THMO ) +82% . Loyalty Ventures ( LYLT ) +51% . Elevation Oncology ( ELEV ) +41% . Jounce ( JNCE ) +40% . Etao International ( ETAO ) +23% . M...
TC BioPharm Shifts Focus to FDA Clinical Trials PR Newswire Company to explore US IND pathway for additional combination trials EDINBURGH, Scotland , March 7, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TC...
Clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, TC BioPharm ( NASDAQ: TCBP ) appoints Dr. Michael Leek to the position of CTO. Dr. Leek resumes operational duties as CTO after stepping down as executi...
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer PR Newswire EDINBURGH, Scotland , Feb. 23, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platfo...
TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies PR Newswire EDINBURGH, Scotland , Feb. 21, 2023 /PRNewswire/ -- TC BioPharm(Holdings) PLC ("TC BioPharm" or the "Company")...
TC BioPharm Announces New Chair of the Board, Arlene Morris PR Newswire EDINBURGH, Scotland , Feb. 14, 2023 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company deve...
TC BioPharm to Reschedule Shareholder Update Call and Webcast PR Newswire Conference Call to be held on Tuesday, February 21 st , 2023 at Noon ET EDINBURGH, Scotland , Feb. 13, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm"...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
TC BioPharm (Holdings) plc Website:
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire 5 patients treated in "safety cohort" showed no drug related Serious Adverse Events Restart of trial after amendment approved by MHRA to increase dose level ...
TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire The Company's lead therapeutic will be available through a newly opened compassionate use program EDINBURGH, Scotland , May 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
2024-05-07 06:02:00 ET 3 Tips for Buying and Selling Penny Stocks During After Hours Trading penny stocks during after-hours sessions offers unique opportunities for investors seeking to capitalize on market movements outside of standard trading hours. Penny stocks , typically price...